正海生物
(300653)
| 流通市值：41.04亿 | | | 总市值：41.04亿 |
| 流通股本：1.80亿 | | | 总股本：1.80亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 413,652,710.67 | 321,781,527.57 | 224,505,570.6 | 109,080,515.27 |
| 营业收入 | 413,652,710.67 | 321,781,527.57 | 224,505,570.6 | 109,080,515.27 |
| 二、营业总成本 | 222,461,772.96 | 172,703,380.33 | 114,279,069.42 | 55,350,360.81 |
| 营业成本 | 41,774,496.05 | 30,917,104.86 | 21,781,225.1 | 11,144,407.46 |
| 税金及附加 | 3,986,215.59 | 3,003,973.41 | 2,075,031.73 | 998,153.04 |
| 销售费用 | 106,313,773.73 | 82,813,123.71 | 53,319,483.38 | 25,430,493.49 |
| 管理费用 | 26,928,262.84 | 23,238,535.98 | 15,247,796.05 | 6,285,875.77 |
| 研发费用 | 44,047,868.37 | 33,278,022.33 | 22,427,008.47 | 11,822,835.7 |
| 财务费用 | -588,843.62 | -547,379.96 | -571,475.31 | -331,404.65 |
| 其中:利息费用 | 5,137.04 | - | - | - |
| 其中:利息收入 | 926,449.16 | 778,155 | 579,564.24 | 337,646.29 |
| 加:公允价值变动收益 | 7,296,508.77 | 5,924,830.89 | 7,011,176.45 | 2,006,399.21 |
| 加:投资收益 | 17,970,331.87 | 13,305,774.5 | 7,769,108.66 | 6,914,978.5 |
| 资产处置收益 | 18,291.27 | - | - | - |
| 信用减值损失(新) | -56,757.27 | -226,485.73 | -397,256.75 | -79,228.07 |
| 其他收益 | 2,151,657.95 | 716,183.4 | 408,526.54 | 284,340 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 218,570,970.3 | 168,798,450.3 | 125,018,056.08 | 62,856,644.1 |
| 加:营业外收入 | 241,795.93 | 144,884.27 | 164,291.37 | 1,540.02 |
| 减:营业外支出 | 416,696.69 | 59,917.19 | 52,140.26 | 6,736.14 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 218,396,069.54 | 168,883,417.38 | 125,130,207.19 | 62,851,447.98 |
| 减:所得税费用 | 27,438,496.09 | 20,548,196.14 | 15,288,398.47 | 9,452,624.65 |
| 六、净利润 | 190,957,573.45 | 148,335,221.24 | 109,841,808.72 | 53,398,823.33 |
| 持续经营净利润 | 190,957,573.45 | 148,335,221.24 | 109,841,808.72 | 53,398,823.33 |
| 归属于母公司股东的净利润 | 190,957,573.45 | 148,335,221.24 | 109,841,808.72 | 53,398,823.33 |
| (一)基本每股收益 | 1.06 | 0.82 | 0.61 | 0.3 |
| (二)稀释每股收益 | 1.06 | 0.82 | 0.61 | 0.3 |
| 九、综合收益总额 | 190,957,573.45 | 148,335,221.24 | 109,841,808.72 | 53,398,823.33 |
| 归属于母公司股东的综合收益总额 | 190,957,573.45 | 148,335,221.24 | 109,841,808.72 | 53,398,823.33 |
| 公告日期 | 2024-04-02 | 2023-10-24 | 2023-08-01 | 2023-04-25 |
| 审计意见(境内) | 标准无保留意见 | | | |